Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v3.21.1
Segment Reporting (Tables)
3 Months Ended
Feb. 28, 2021
Segment Reporting [Abstract]  
Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, Interest Expense, Income Tax Expense and Assets by Segment

The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, interest expense, and income tax expense for the three months ended February 28, 2021 and February 29, 2020:

 

 

 

For the three

months ended

February 28,

2021

 

 

For the three

months ended

February 29,

2020

 

Net revenue

 

 

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

6,738,631

 

 

$

7,406,288

 

PrepaCyte®-CB

 

 

38,000

 

 

 

60,407

 

Public cord blood banking

 

 

83,986

 

 

 

154,079

 

Total net revenue

 

$

6,860,617

 

 

$

7,620,774

 

Cost of sales

 

 

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

1,640,015

 

 

$

2,055,075

 

PrepaCyte®-CB

 

 

34,880

 

 

 

41,117

 

Public cord blood banking

 

 

337,302

 

 

 

406,952

 

Total cost of sales

 

$

2,012,197

 

 

$

2,503,144

 

Depreciation and amortization

 

 

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

14,368

 

 

$

37,327

 

PrepaCyte®-CB

 

 

6,895

 

 

 

6,894

 

Public cord blood banking

 

 

 

 

 

 

Total depreciation and amortization

 

$

21,263

 

 

$

44,221

 

Operating income

 

 

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

1,492,353

 

 

$

1,489,548

 

PrepaCyte®-CB

 

 

(3,777

)

 

 

12,396

 

Public cord blood banking

 

 

(253,315

)

 

 

(252,874

)

Total operating income

 

$

1,235,261

 

 

$

1,249,070

 

Interest expense

 

 

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

280,219

 

 

$

365,299

 

PrepaCyte®-CB

 

 

 

 

 

 

Public cord blood banking

 

 

 

 

 

 

Total interest expense

 

$

280,219

 

 

$

365,299

 

 

The following table shows the assets by segment as of February 28, 2021 and November 30, 2020:

 

 

 

As of

February 28,

2021

 

 

As of

November 30,

2020

 

Assets

 

 

 

 

 

 

 

 

Umbilical cord blood and cord tissue stem cell service

 

$

93,405,068

 

 

$

34,215,780

 

PrepaCyte®-CB

 

 

235,248

 

 

 

302,683

 

Public cord blood banking

 

 

11,624,145

 

 

 

11,681,631

 

Total assets

 

$

105,264,461

 

 

$

46,200,094